[Clinical study on effect of quyu xiaoban capsule on regression of atherosclerosis]

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2005 Jun;25(6):499-501.
[Article in Chinese]

Abstract

Objective: To study the effect of Quyu Xiaoban capsule (QXC) on regression and stabilization of atherosclerotic plaque with high-frequency ultrasound technique.

Methods: Eighty patients with atherosclerosis (AS) were randomly divided into the treated group and the control group, level of blood lipids was measured, and intima-media thickness (IMT) and corrected value of image average echo intensity (AIIc%) were determined by ultrasound technique at the beginning of experiment and after being treated for six months.

Results: The levels of total cholesterol (TC) and low density lipoprotein cholesterol (LDL-C) were significantly decreased in the treated group after treatment (68.12 +/- 5.54 vs 61.43 +/- 5.37, P<0.05). The AIIc% of fatty atherosclerotic plaque was significantly increased after treatment (68.12 +/- 5.54 vs 61.43 +/- 5.37), and the change rate of AIIc% in the treated group was significantly different to that in the control group (10.9 +/- 5.1% vs 2.5 +/- 5.5%, P < 0.05).

Conclusion: QXC can significantly lower the blood lipids level, delay the progress and enhance the stability of atherosclerotic plaque.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Atherosclerosis / diagnostic imaging*
  • Atherosclerosis / drug therapy*
  • Atherosclerosis / pathology
  • Cholesterol / blood
  • Cholesterol, LDL / blood
  • Coronary Artery Disease / diagnostic imaging
  • Coronary Artery Disease / drug therapy
  • Coronary Artery Disease / pathology
  • Drugs, Chinese Herbal / therapeutic use*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Phytotherapy*
  • Ultrasonography

Substances

  • Cholesterol, LDL
  • Drugs, Chinese Herbal
  • Cholesterol